Mononuclear gold(III) complexes with phenanthroline ligands as efficient inhibitors of angiogenesis: A comparative study with auranofin and sunitinib

The anti-angiogenic potential of mononuclear gold(III) complexes with 1,7- and 4,7-phenanthroline ligands is markedly higher than that of the clinically relevant auranofin and sunitinib, making them good candidates for further development towards anti-angiogenic drugs.115